Uscom Saham

Uscom EPS

Laba per Saham (EPS) dari Uscom (UCM.AX) pada 16 Agu 2026 adalah -0,02 AUD. Tahun sebelumnya, Laba per Saham (EPS) adalah -0,01 AUD — perubahan sebesar 54,23% (lebih rendah).

EPS

-0,02AUD

YoY

54,23%

Terakhir Diperbarui:

Laba per Saham (EPS) dari Uscom adalah 2026 -0,02 AUD. Laba per Saham (EPS) dari Uscom adalah 2025 -0,01 AUD. Menurun 54,23% lebih rendah dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Uscom Analisis saham

Apa yang dilakukan Uscom? Uscom Ltd is an Australian company that was founded in 2000. The company focuses on the development, manufacturing, and marketing of medical equipment and devices, with a focus on cardiovascular diagnostics. The company is headquartered in Sydney, Australia, and has branches in Europe, North America, and Asia. Uscom consists of a team of experienced scientists, engineers, and medical professionals who collaborate to manufacture and offer high-quality products that are recognized in the medical field worldwide. Uscom's business model is to develop innovative devices that help doctors and medical professionals diagnose and treat their patients more effectively. Over the years, the company has diversified its portfolio and now offers a variety of products that can be classified into different categories. One of Uscom's main divisions is the manufacturing of ultrasound devices that can be used to measure blood flow, blood pressure, and other important cardiovascular parameters. These devices are particularly useful in the diagnosis and monitoring of patients with cardiovascular diseases such as hypertension, heart failure, and stroke. Uscom also offers a range of devices specifically designed for use in intensive care units and emergency rooms. These devices include non-invasive blood pressure monitors, ventilators, and monitoring systems that enable quick and accurate patient monitoring. These devices are used by medical professionals worldwide to save lives and improve the treatment of critical illnesses. In addition to medical devices, Uscom also provides a variety of training and continuing education programs for medical professionals. These trainings include courses on device usage as well as general trainings on cardiovascular health and diagnosis. In recent years, Uscom has specialized in the development and marketing of telemedicine solutions. These solutions allow doctors and patients to communicate and exchange information remotely. This is particularly useful in providing care to patients in remote areas and in other situations where access to medical professionals is limited. One of Uscom's latest developments is a portable ultrasound Doppler device that can be used to measure blood flow, stroke volume, and other important cardiovascular parameters. This device is lightweight and easy to use, enabling doctors to diagnose patients quickly and accurately in any clinical setting. Overall, Uscom has established a good reputation in the medical industry and is considered a leading company in cardiovascular diagnostics. The company continues its efforts to develop innovative products and solutions that can improve the lives of patients worldwide. Uscom adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Uscom

Laba per Saham (EPS) Uscom adalah -0,02 AUD pada tahun 2026.

Laba per Saham (EPS) dari Uscom berubah dari -0,01 AUD menjadi -0,02 AUD, mewakili perubahan 54,23%. Nilainya lebih rendah daripada tahun sebelumnya.

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Laba per Saham (EPS) Uscom sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

Laba per Saham mengukur porsi laba perusahaan yang dialokasikan untuk setiap saham yang beredar. Metrik ini adalah metrik kunci untuk menilai profitabilitas perusahaan berdasarkan per saham.

EPS = Laba Bersih / Saham yang Beredar

Access this data via the Eulerpool API

Laporan Laba Rugi — Uscom

Semua Metrik Kunci — Uscom